Abstract: Di-(2-ethylhexyl) Phthalate Upregulates ATF3 Expression and Suppresses Apoptosis in Mouse Genital Tubercle: Xing LIU, et al. Department of Pediatric Urology, Chongqing Children's Hospital, Chongqing Medical University, ChinaObjectives: To investigate the effect of di-(2-ethylhexyl) phthalate (DEHP) on the expression of activating transcription factor 3 (ATF3) and apoptosis of fetal mouse genital tubercle (GT). Methods: In this developmental toxicity study, pregnant C57BL/6 mice were exposed to corn oil or DEHP (100 or 500 mg/kg/ day) from embryonic day 12 (ED12) to ED16. Apoptosis was characterized by Terminal transferase dUTP nick end labeling (TUNEL) assay. Using RT-PCR and western blot, the expressions of ATF3 and apoptosisrelated genes (P53, Bcl-2 and Bax) were investigated. Results: Apoptosis of fetal mouse GT cells notably decreased after DEHP treatment. DEHP activated ATF3 both at the mRNA and protein levels in GT. Furthermore, pro-apoptotic P53 was downregulated and the ratio of anti-apoptotic (Bcl-2)/pro-apoptotic (Bax) was not significantly changed. Conclusions: These results suggest that DEHP may induce external genital defects via a mechanism involving apoptosis, which might correlate with the regulation of ATF3 and P53 expressions. (J Occup Health 2009; 51: 57-63) 
Di-(2-ethylhexyl) phthalate (DEHP) is by far the most commonly used plasticizer. It is an ingredient of products such as toys, medical tubing and blood storage bags. It has potentially adverse effects on the reproductive organs, liver and kidney 1) . Especially among pediatric populations, DEHP can induce a wide range of developmental disorders and reproductive toxicities, and it is significantly correlated with the occurrence of some congenital diseases, such as hypospadias and cryptorchidism [2] [3] [4] [5] . Our previous work demonstrated that DEHP can cause hypospadias in the male offspring of pregnant females exposed to it 6) , but the precise molecular target of DEHP in affected external genitalia toxicity remains unknown.
Activating transcription factor 3 (ATF3), a member of the ATF/CREB family of basic leucine zipper-type transcription factors 7) , is an immediate early gene that is acutely responsive to a wide variety of physiological and pathological stimuli, including cytokines and genotoxic stress agents 8, 9) . In a recent report, nucleotide polymorphisms (SNP) mutations of ATF3 were found in patients with hypospadias, indicating that ATF3 gene variants might be related to the risk of hypospadias in humans 10) . ATF3 was also upregulated in the penile skin tissues of boys with hypospadias 11) . It is of note that ATF3 has been strongly indicated as contributing to the development of hypospadias due to its estrogenresponsive character, since external estrogen causes mouse hypospadias and significantly upregulates ATF3 expression [12] [13] [14] . Because phthalates have been shown to mimic estrogen and are capable of binding to estrogen receptor 15, 16) , we hypothesized that DEHP might also activate ATF3 of mouse GT.
Apoptosis is tightly related with removal unwanted or abnormal cells in embryonic development. Although apoptosis plays a key role in the fusion process of urogenital swellings in both humans and mice 17) , only a few reports have focused on the relationship between apoptosis and external genitalia malformation of mammals. Studies have shown that DEHP can suppress apoptosis in some cell types. For example, DEHP inhibited tamoxifen-induced apoptosis in GH3 pituitary cells 18) , inhibited apoptosis of Syrian hamster embryo cells 19) and cultured normal mouse Sertoli cells 20) . However, whether or not DEHP influences apoptosis in GT has not yet been reported.
In the present study, we exposed pregnant mice to DEHP, to investigate the change of apoptosis and expression of ATF3 and apoptosis-related genes/proteins in fetal GT, to examine the role of DEHP in the pathogenesis of hypospadias.
Materials and Methods

Animals and treatments
This study was approved by the Animal Ethical Committee of the Institute of Zoology and the Chongqing Medical University. Mature C57BL/6 mice were obtained from the Experimental Animal Centre of Chongqing Medical University. Female mice were mated overnight with a male, and noon of the day on which a vaginal plug was found was appointed as embryonic day 0.5 (ED 0.5). ED12 mice were randomly divided into the following 3 groups (n=30): Vehicle Control, mice gavaged with 0.1 ml corn oil (Sigma-Aldrich Inc., St, Louis, MO, USA) only; Treated, mice gavaged with 100 mg/kg/day and 500 mg/kg/day of DEHP (purity≥99%, Shanghai Chemical Reagents Company, Shanghai, China) suspended in 0.1 ml corn oil from ED12 to ED16. The dosage gradient of DEHP was based on the results of Gray et al. 21) and Mylchreest et al. 22) who showed that DEHP had similar effects to di-n-butyl phthalate (DBP) on rodent reproductive organs: DBP 100 mg/kg/day was the lowest observed adverse effect level and hypospadias could be noticed in ≥500 mg/kg/day group. At ED16.5, pregnant mice were sacrificed by cervical dislocation. Fetuses were removed from the uterus, and the sex of each fetal mouse was determined by gonadal analysis.
Immunofluorescent staining
GTs were fixed in 4% paraformaldehyde, dehydrated, embedded in paraffin wax and serially sectioned (5 µm thick). After deparaffinization and rehydration, paraffin sections were incubated with 3% goat serum for 20 min, and then were incubated with ATF3 antibody (1:100 dilution, sc-188, Santa Cruz Biotechnology, Inc., USA) at 4°C overnight. Next they were washed in phosphatebuffered saline (PBS) (3 × 10 min) and incubated with FRITC-conjugated sheep anti-rabbit IgG (1:100 dilution, ZF-0316, Zhongshan Co., Beijing, China) at 37°C for 1 hour. Then they were again washed in PBS (4 × 10 min), and a mixture of ProLong mounting medium and ProLong Antifade reagent was applied to the slides, which were then covered with coverslips. Fluorescent images were observed under a confocal laser-scanning microscope using a Leica TCS SP confocal system attached to a Leica DM IRBE microscope and a 568 nm laser wavelength for analysis.
Analysis of cell death
We chose ED16.5 for sacrifice because apoptosis could not be found after that time. Terminal transferase dUTP nick end-labeling (TUNEL) analysis for the detection of apoptotic cells in the GT was performed using an in situ cell death detection kit (Roche, Germany) on fixed p a r a f f i n -e m b e d d e d t i s s u e s . B r i e f l y, a f t e r deparaffinization and rehydration, slides were placed in citrate buffer (0.1 M, pH 6.0), microwave irradiated for 1 min, and cooled by adding double-distilled water. Then they were immersed for 30 min in 0.1 M Tris-HCL (pH 7.5, 3% BSA, 20% normal bovine serum), rinsed twice with PBS, before adding TUNEL reaction mixture to the sections and incubating for 60 min at 37°C in the dark. Converter-POD was added to the slides, and incubated for 30 min at 37°C, then DAB color was developed and counterstained with methyl green. Each experiment was repeated in at least three independent series of assays. Apoptotic cells were calculated under five high power fields randomly selected, at least 1,000 cells per field. The percentage of positive cells to total cells was calculated as an Apoptosis Index.
RNA Preparation and semiquantitative RT-PCR
GTs were collected. Total RNA was extracted using the Trizol method (Invitrogen, California, USA) according to the manufacturer's instructions, and quantified by spectrophotometry at 260 nm. Firststranded cDNA was synthesized using 4 µg total RNA and a RT-PCR kit. The subsequent PCR reaction mixture was cDNA template 10 µl, 10 × PCR buffer 5 µl, Taq mix DNA polymerase 1 µl, 10 pmol (1 µl) each of sense and antisense primers of ATF3, Bcl-2, Bax, P53 cDNA, and double-distilled water 32 µl. The PCR condition was as follows: predenaturing at 94°C for 5 min followed by 30 cycles (Bcl-2 by 28 cycles) of reaction at 94°C for 30 s, 60°C for 30 s, 52°C for 50 s and final extension at 72°C for 5 min. β-actin was used as the internal control. Equal amounts (7 µl) of PCR products from each group were analyzed on a 1.5% agarose gel stained with ethidium bromide and the target bands were analyzed densitometrically by using Vistra Fluor Imager SI (Molecular Dynamics Inc. USA). The ratio of the target gene and β-actin OD value was used to represent the relative intensity of the target product. Primers were designed with Primer Premier 5.0 software according to the mouse sequences obtained from Medline. The primers used are shown in Table 1 .
Western blot analysis
Total protein was isolated and quantified. GT tissue samples were homogenized in 300 µl of ice-cold lysis buffer (50 mM NaCl, 0.5% Triton X-100, 10 mM HEPES, 1 mM EDTA, 0.05% 2-mercaptoethanol, 0.1 mM polymethylsulphonate and 10 µg/ml aprotinin). After centrifugation at 14,000 rpm for 20 min at 4°C, supernatant lysates were collected, and the protein concentration was measured using the BCA assay reagent (Bioteke corporation, Beijing, China) according to the manufacturer's protocol. For western blotting, 50 µg of whole cell lysates were resolved by SDS-PAGE and transferred onto PVDF membrane (Immobilon, Bedford, MA, USA). After blocking in 20 mM Tris-HCl (pH 7.6, containing 150 mmol/l NaCl, 0.1% Tween-20, and 5% non-fat dry milk), the membranes were incubated with primary antibodies against ATF3 (sc-188), P53 (sc-6243), Bcl-2 (sc-492) or Bax (sc-526) (1:200, Santa Cruz Biotechnology, Inc., USA) overnight at 4°C. Peroxidaseconjugated goat anti-rabbit IgG (MultiSciences Biotech Co., Ltd. Hangzhou, China) was used as the secondary antibody and detected using an ECL detection kit (keygen, Nanjing, China) according to the manufacturer's instructions. The average densitometric analysis of the bands was obtained from the protein extracts of the GTs of the ten mice in each group from at least three independent experiments. β-actin immunoblotting was used as a protein loading control.
Statistical analysis
All experiments were performed at least 3 times. Statistical tests were carried out with SPSS13.0 (SPSS incorporated, Chicago, USA); all values are expressed as mean ± SD. ANOVA was used to when more than two groups were compared, and when the results were significant (p<0.05), Dunnett's test was performed for multiple comparison analysis. The chi-square test was used to compare the apoptosis index. p<0.05 was considered to be statistically significant.
Results
Apoptosis was suppressed in mouse GT
The TUNEL stain showed that apoptosis was localized to the urethral plate and mesenchymal cells in ED16.5 control GT. In contrast, the DEHP 500 mg/kg/day treated group exhibited significantly reduced apoptosis in the urethral plate and mesenchyme, and only scattered apoptosis cells were noticed. Apoptosis in the distal GT was calculated, and the apoptosis index of the DEHP 500 mg/kg/day group was significantly lower than that of the control group (p<0.01) (Fig. 1) . However, we did not find a difference in the apoptosis index between the control with DEHP 100 mg/kg/day groups.
Histology of mouse GT
In the control group, ATF3 was scattered in the mesenchyme under the urethral plate, and it had significantly increased expression in the DEHP-treated groups, exhibiting a stronger and wider distribution in the flanking mesenchyme, the basal layer of urethral epithelium and the urethral plate (Fig. 2) .
The expression of mRNA and protein of target genes
As shown in Fig. 3 , the ratio of band density of the ATF3 to β-actin in each DEHP treated group was significantly higher than that of the control group (p<0.05 or p<0.01). Similar to mRNA expression, the protein levels of ATF3 increased with the dose of DEHP (Fig.  4) . P53, Bcl-2 and Bax mRNA and protein levels decreased with increasing dose of DEHP (Figs. 3 and 4) , but the Bcl-2/Bax ratios did not manifest any marked difference from that of the control (p>0.05).
Discussion
Regulation of apoptosis during development is one of the characteristic requirements for proper outgrowth of embryonic anlagen. The formation of the urethra starts with the early adhesion of the arms of the GT. During this morphogenesis, apoptosis plays a very important role in canalization of the urethral plate and the removal of overlying ectoderm in the fusion processes of urogenital swelling 17, 23) . In the hypospadiac phenotype of Hoxa13 and BMPr1a mutant mice, reduced apoptosis was found in GT and it was speculated that it might be related to the inhibition of urethral plate canalization and the suppression of urethral seam formation, suggesting that abnormal apoptosis is a contributing factor to hypospadias 24, 25) . Our previous study observed that DEHP (at a 500 mg/kg/day dose) induced mouse hypospadias at a rate of almost 75% 6) , and the present results showed that apoptosis was markedly reduced in the distal region of the urethral plate and GT mesenchyme. Taken together, the toxicology of DEHP may affect GT development through a mechanism including apoptosis.
Liu et al. 11) conjectured that over-expressed ATF3 can inhibit formation of male normal GT and/or urethral seam. ATF3 may not be expressed as a protective response for cells coping with stress, but as a part of the cellular response that leads to hypospadias formation. However, the pathological mechanism of ATF3 expression remains unexplored. We note that DEHP upregulates ATF3 expression both at the mRNA and protein level. ATF3 is a bZip protein that binds to ATF/CRE or AP-1 sites, forming a homodimer or heterodimer with other bZip proteins. ATF3 homodimer has been shown to be a transcription repressor. Although the exact physiological function of ATF3 remains unclear, some studies have documented a putative anti-apoptotic role for it. For example, ATF3 positively contributed to neuronal survival in stress-induced death 26) , and over-expression of the gene has been shown to confer protection from DNA damageinduced apoptosis 27) . Also, ATF3 inhibited doxorubicininduced apoptosis in cardiac myocytes 28) . DEHP treatment increased ATF3 expression, at ED16.5 with a decrease of apoptosis. This raises the possibility that ATF3 might play an anti-apoptosis role in GT, and that DEHP might inhibit apoptosis during GT formation, in part, through an ATF3 signaling pathway.
In the present study, the upregulation of ATF3 was accompanied by downregulation of P53 transcription. As an apoptosis suppressor protein, p53 is activated in response to DNA damage or a wide range of stress stimuli. It is interesting to note that ATF3 directly binds p53 and represses the p53-dependent trans-activation of the collagenase gene promoter 29) . Kawauchi et al. 30) also demonstrated that ATF3 protected endothelial cells from TNF-α-induced apoptosis by downregulating p53. Based on our TUNEL, RT-PCR and western blot findings, we propose that it is possible that since P53 expression was not significantly different from the control in the DEHP 100 mg/kg/day group (Figs. 3 and 4) , there was no significant difference in the levels of apoptosis. In contrast, the higher dose of DEHP (500 mg/kg/day) remarkably decreased P53 expression, which may have suppressed apoptosis. All of the above data suggest that cells of GT become more resistant to apoptotic stimulus after exposure to DEHP, and that P53 might be involved in the ATF3 signaling pathway which suppresses apoptosis. Due to methodological difficulties, this in vivo study did not address the mechanistic cause and effect of ATF3-P53 signaling in DEHP-mediated apoptosis.
It was previously reported that DEHP increased the Bcl-2/Bax ratio and inhibited apoptosis in Syrian hamster embryo cells 19) and in MCF-7 cells 18) . The ratio between anti-apoptotic Bcl-2 and pro-apoptotic Bax is a key factor for determining apoptosis. When Bcl-2 is expressed excessively, the Bcl-2-Bax heterogeneous dimer predominates, inhibiting apoptosis 31) . When Bax is expressed excessively, Bax-Bax homogeneous dimers or monomers predominate, promoting apoptosis. In this study, we found the expression of Bcl-2 and Bax were both decreased in the DEHP treatment groups, but the Bcl-2/Bax ratios were not different from that of the control group. Therefore, Bcl-2 and Bax might not participate in the abnormal apoptosis.
In summary, the present study demonstrates that DEHP suppresses apoptosis and upregulates ATF3 in the GT of fetal mice, and over-expressed ATF3 might play a potential anti-apoptosis role in the toxicology of DEHP. In addition, P53, but not Bcl-2 or Bax, participates in the suppression of GT apoptosis.
